E-LIB Suche - Ergebnisse für: Jonker, Carla J.

1

Real world evidence: Perspectives from a European Society o..:

Szymański, Piotr ; Weidinger, Franz ; Lordereau-Richard, Isabelle...
European Heart Journal - Quality of Care and Clinical Outcomes. 9 (2023) 2 - p. 109-118 , 2023

Link: https://doi.org/10.1093/..

2

Contribution of Real‐World Evidence in European Medicines A..:

Bakker, Elisabeth ; Plueschke, Kelly ; Jonker, Carla J....
Clinical Pharmacology & Therapeutics. 113 (2022) 1 - p. 135-151 , 2022

Link: https://doi.org/10.1002/..

3

Collection of Data on Adverse Events Related to Medicinal P..:

Plueschke, Kelly ; Jonker, Carla ; Strassmann, Valerie.
Drug Safety. 45 (2022) 7 - p. 747-754 , 2022

Link: https://doi.org/10.1007/..

4

Contribution of patient registries to regulatory decision m..:

Jonker, Carla J. ; Bakker, Elisabeth ; Kurz, Xavier.
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

5

Capturing Data in Rare Disease Registries to Support Regula..:

Jonker, Carla J. ; de Vries, Sieta T. ; van den Berg, H. Marijke...
Drug Safety. 44 (2021) 8 - p. 853-861 , 2021

Link: https://doi.org/10.1007/..

6

Inhibitor development in previously untreated patients with..:

Jonker, Carla J. ; Oude Rengerink, Katrien ; Hoes, Arno W...
Haemophilia. 26 (2020) 5 - p. 809-816 , 2020

Link: https://doi.org/10.1111/..

7

Drug Registries and Approval of Drugs: Promises, Placebo, o..:

Jonker, Carla J. ; Kwa, Marcel S.G. ; van den Berg, H. Marijke..
Clinical Therapeutics. 40 (2018) 5 - p. 768-773 , 2018

Link: https://doi.org/10.1016/..

8

Registries supporting new drug applications:

Jonker, Carla J. ; van den Berg, H. Marijke ; Kwa, Marcel S.G...
Pharmacoepidemiology and Drug Safety. 26 (2017) 12 - p. 1451-1457 , 2017

Link: https://doi.org/10.1002/..

9

Additional Efficacy of Milligram-Equivalent Doses of Atorva..:

van Dam, Marjel ; Basart, Dick C.G. ; Janus, Charles...
Clinical Drug Investigation. 19 (2000) 5 - p. 327-334 , 2000

Link: https://doi.org/10.2165/..

10

Contribution of Real-World Evidence in European Medicines A..:

Bakker, Elisabeth ; Plueschke, Kelly ; Jonker, Carla J...
https://research.rug.nl/en/publications/433cbff8-1b03-4aef-857f-e653fcbcde33. , 2023

Link: https://hdl.handle.net/1..

11

Contribution of patient registries to regulatory decision m..:

Jonker, Carla J ; Bakker, Elisabeth ; Kurz, Xavier.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386590/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Contribution of Real‐World Evidence in European Medicines A..:

Bakker, Elisabeth ; Plueschke, Kelly ; Jonker, Carla J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099093/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Collection of Data on Adverse Events Related to Medicinal P..:

Plueschke, Kelly ; Jonker, Carla ; Strassmann, Valerie.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296377/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Contribution of patient registries to regulatory decision m..:

Jonker, Carla J ; Bakker, Elisabeth ; Kurz, Xavier.
https://research.rug.nl/en/publications/b495abe8-aac0-4f02-a3b6-373a89bf6943. , 2022

Link: https://hdl.handle.net/1..

15

Capturing Data in Rare Disease Registries to Support Regula..:

Jonker, Carla J ; de Vries, Sieta T ; van den Berg, H. Marijke...
https://research.rug.nl/en/publications/c593b067-8439-49ad-b1cc-0d02140cd26c. , 2021

Link: https://hdl.handle.net/1..